Package 73776-022-01

Brand: proleukin

Generic: aldesleukin
NDC Package

Package Facts

Identity

Package NDC 73776-022-01
Digits Only 7377602201
Product NDC 73776-022
Description

1 VIAL, SINGLE-DOSE in 1 CARTON (73776-022-01) / 1 mL in 1 VIAL, SINGLE-DOSE

Marketing

Marketing Status
Marketed Since 2024-07-15
Brand proleukin
Generic aldesleukin
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "29ba86b1-f672-482e-e063-6394a90a931f", "openfda": {"nui": ["N0000178328", "N0000009391", "M0011506", "N0000175667"], "unii": ["M89N0Q7EQR"], "rxcui": ["105648", "307816"], "spl_set_id": ["f3c516ad-d405-4fbe-af6a-962080dbfa7d"], "pharm_class_cs": ["Interleukin-2 [CS]"], "pharm_class_pe": ["Increased Lymphocyte Activation [PE]", "Increased Lymphocyte Cell Production [PE]"], "pharm_class_epc": ["Lymphocyte Growth Factor [EPC]"], "manufacturer_name": ["Iovance Biotherapeutics, Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (73776-022-01)  / 1 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "73776-022-01", "marketing_start_date": "20240715"}], "brand_name": "PROLEUKIN", "product_id": "73776-022_29ba86b1-f672-482e-e063-6394a90a931f", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Increased Lymphocyte Activation [PE]", "Increased Lymphocyte Cell Production [PE]", "Interleukin-2 [CS]", "Lymphocyte Growth Factor [EPC]"], "product_ndc": "73776-022", "generic_name": "aldesleukin", "labeler_name": "Iovance Biotherapeutics, Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "PROLEUKIN", "active_ingredients": [{"name": "ALDESLEUKIN", "strength": "1.1 mg/mL"}], "application_number": "BLA103293", "marketing_category": "BLA", "marketing_start_date": "19920505", "listing_expiration_date": "20261231"}